ArticleHuman cell2026
Gata1-mediated Hras transcription stimulates blood-brain barrier injury in ischemic stroke through activation of the ERK pathway.
Article in Human cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Disruption of the blood-brain barrier (BBB) is an essential pathological outcome of ischemic stroke (IS). This study aimed to prove that Gata1 upregulates Hras and promotes ERK signaling, leading to BBB damage in IS. Middle cerebral artery occlusion (MCAO) was used for in vivo modeling, and cerebrovascular endothelial cell-specific adeno-associated viruses were used for Gata1/Hras expression manipulation. TTC staining, Evans blue extravasation assay, and Western blot analysis were conducted to investigate the role of Gata1 and Hras in BBB injury. Mouse bEnd.3 cells were exposed to oxygen-glucose deprivation (OGD), and lentivirus-mediated genetic interventions were performed. Viability, lactate dehydrogenase release, and BBB permeability were assessed in bEnd.3 cells. The regulation of Gata1 on Hras was examined using ChIP-qPCR and a dual-luciferase assay. Gata1 was upregulated in mice after MCAO, and Gata1 knockdown reduced cerebral infarction and decreased BBB leakage in mice. Gata1 knockdown also alleviated OGD-induced BBB permeability and bEnd.3 cell injury. Gata1 transcriptionally activated Hras and promoted the ERK signaling. Hras reactivation reversed BBB injury in MCAO mice and BBB permeability and bEnd.3 cell injury alleviated by Gata1 knockdown. Overall, Gata1 transcriptionally upregulates Hras expression and activates the ERK signaling to exacerbate BBB dysfunction in mice after MCAO.
Indexed as
Identifiers
42189366What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.